Claims
- 1. A compound of the formula (I): ##STR202## wherein R.sup.1 and R.sup.2 each, independently, is: (i) hydrogen,
- (ii) C1-4 alkyl,
- (iii) C1-4 alkoxy,
- (iv) C2-5 acyl,
- (v) halogen,
- (vi) nitro,
- (vii) benzoyl or
- (viii) COOR.sup.4 (in which R.sup.4 is C1-3 alkyl);
- A is bond, C1-4 alkylene or ##STR203## (in which R.sup.5 and R.sup.6 each independently, is hydrogen or C1-4 alkyl);
- R.sup.3 is ##STR204## (in which R.sup.7 and R.sup.8 each, independently, is (1) hydrogen,
- (2) phenyl,
- (3) C7-10 phenylalkyl,
- (4) phenyl or C7-10 phenylalkyl each of which is substituted by one or two substituents optionally selected from C1-4 alkyl, halogen and R.sup.11 --COOR.sup.12
- (in which R.sup.11 is
- (a) bond,
- (b) C1-8 alkylene,
- (c) C2-8 alkenylene or
- (d) C2-8 alkynylene, and
- R.sup.12 is
- (a) hydrogen,
- (b) C1-4 alkyl,
- (c) C7-10 phenylalkyl,
- (d) phenyl,
- (e) allyl or
- (f) propargyl),
- (5) C1-10 alkyl,
- (6) C2-10 alkenyl having one to three double bonds,
- (7) C2-10 alkynyl having one or two triple bonds,
- (8) R.sup.11a --COXR.sup.12
- (in which R.sup.11a is
- (a) bond,
- (b) C1-8 alkylene,
- (c) C2-8 alkylene in which one or two carbon atoms in the main chain are replaced by sulfur, or sulfur and phenylene,
- (d) C2-8 alkenylene,
- (e) C4-8 alkenylene In which one or two carbon atoms in the main chain are replaced by sulfur, or sulfur and phenylene,
- (f) C2-8 alkynylene, or
- (g) C4-8 alkynylene in which one or two carbon atoms in the main chain are replaced by sulfur, or sulfur and phenylene,
- X is oxygen or --NH--, and R.sup.12 is the same meaning as hereinbefore defined),
- (9) C1-4 alkyl which is substituted by a 7-14 membered, bi- or tri-cyclic hetero ring containing one nitrogen, or
- (10) C3-7 cycloalkyl);
- R.sup.9 is
- (1) hydrogen,
- (2) C1-8 alkyl,
- (3) C7-10 phenylalkyl,
- (4) C2-10 alkenyl having one to three double bonds,
- (5) C2-10 alkynyl having one or two triple bonds,
- (6) R.sup.11 --COOR.sup.12 (in which R.sup.11 and R.sup.12 are the same meaning as hereinbefore defined), or
- (7) C3-7 cycloalkyl;
- with the proviso that
- (i) both R.sup.7 and R.sup.8 do not represent hydrogen at the same time, and
- (ii) when at least one group in R.sup.7, R.sup.8 and R.sup.9 represents the group containing t-butyl ester, the other groups do not represent the group containing corboxy;
- or an acid-addition salt thereof.
- 2. A compound according to claim 1, wherein one of R.sup.7 and R.sup.8 is C1-4 alkyl which is substituted by a 7-14 membered, bi- or tri-cyclic hetero ring containing one nitrogen.
- 3. A compound according to claim 1, wherein one of R.sup.7 and R.sup.8 is phenyl,
- C7-10 phenylalkyl,
- phenyl or C7-10 phenylalkyl which is substituted by one or two substituents optionally selected from C1-4 alkyl, halogen and R.sup.11 --COOR.sup.12
- (in which R.sup.11 and R.sup.12 are as defined in claim 1)
- R.sup.11a --COXR.sup.12
- (in which R.sup.11a is
- (c) C2-8 alkylene in which two carbon atoms in the main chain are replaced by sulfur and phenylene or
- (e) C4-8 alkenylene in which two carbon atoms in the main chain are replaced by sulfur and phenylene or
- (g) C4-8 alkynylene in which two carbon atoms in the main chain are replaced by sulfur and phenylene
- (in which X and R.sup.12 are as defined in claim 1) or C3-7 cycloalkyl.
- 4. A compound according to claim 1, wherein one of R.sup.7 and R.sup.8 is
- (5) C1-10 alkyl,
- (6) C2-10 alkenyl having one to three double bonds,
- (7) C2-10 alkynyl having one or two triple bonds, or
- (8) R.sup.11a --COXR.sup.12
- (in which R.sup.11a
- (a) bond,
- (b) C1-8 alkylene,
- (c) C2-8 alkylene in which a carbon atom in the main chain is replaced by sulfur,
- (d) C2-8 alkenylene,
- (e) C4-8 alkenylene in which a carbon atom in the main chain is replaced by sulfur,
- (f) C2-8 alkynylene, or
- (g) C4-8 alkynylene in which a carbon atom in the main chain is replaced by sulfur,
- (in which X and R.sup.12 are as defined in claim 1).
- 5. A compound according to claim 1, which is p-(p-amidinophenoxycarbonyl)benzoic acid N-[1-ethoxycarbonyl-2-(3-indolyl)]ethylamide.
- 6. A compound according to claim 1, which is
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-ethoxycarbonylmethyl-N-phenylamide,
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-(1-ethoxycarbonyl-2-phenyl)ethylamide,
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-3,5-bis(ethoxycarbonyl)phenylamide,
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-(1-ethoxycarbonyl-2-(4-ethoxycarbonylphenylmethylthio))ethylamide,
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-cyclopropyl-N-ethoxycarbonylmethylamide or
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-cyclohexyl-N-carboxymethylamide.
- 7. A compound according to claim 1, which is
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-(2-ethoxycarbonylethyl)-N-isopropylamide,
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-allyl-N-ethoxycarbonylmethylamide,
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-carboxymethyl-N-allylamide,
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-propargyl-N-ethoxycarbonylmethylamide,
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-allyl-N-((1-ethoxycarbonyl-2-ethoxycarbonylmethylthio)ethyl)amide or
- p-(p-amidinophenoxycarbonyl)-.alpha.-methylcinnamic acid N-(1,1-bis(ethoxycarbonyl)methyl)-N-ethoxycarbonylmethylamide.
- 8. A pharmaceutical composition which comprises, as active ingredient, an effective amount of a compound of the formula (I) depicted in claim 1, or an acid addition salt thereof, with a carrier or coating.
- 9. A method for the prevention and/or treatment in animals, including man, of inflammatory diseases, allergic diseases, disseminated intravascular coagulation, pancreatitis, severity in pancreatitis or multiple organ failure, which comprises the administration to a patient of an effective amount of a compound of the formula (I) depicted in claim 1, or an acid addition salt thereof.
Priority Claims (2)
Number |
Date |
Country |
Kind |
4-274992 |
Sep 1992 |
JPX |
|
5-96758 |
Mar 1993 |
JPX |
|
Parent Case Info
This is a division of application Ser. No. 08/396,784, filed Mar. 1, 1995; which in turn is a division of application Ser. No. 08/121,499, filed Sep. 16, 1993 now U.S. Pat. No. 5,432,178.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4514416 |
Fujii et al. |
Apr 1985 |
|
4570006 |
Fujii et al. |
Feb 1986 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
1260068 |
Nov 1986 |
JPX |
1260074 |
Nov 1986 |
JPX |
Non-Patent Literature Citations (1)
Entry |
Japan J. Pharmacol., 52, 23-34, 1990, , Oda et al., "Pharmacological Studies on 6-Amidino-2-Naphthyl[4-(4,5-dihydro-1 H-Imidazol-2-yl)amino]Benzoate Dimethane Sulfonate (FUT-187). I: Inhibitory Activities on Various Kinds of Enzymes in Vitro and Anticomplement Activity In Vivo". |
Divisions (2)
|
Number |
Date |
Country |
Parent |
396784 |
Mar 1995 |
|
Parent |
121499 |
Sep 1993 |
|